ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    The Impact of Metabolic Syndrome and Prevalent Liver Disease on Living Donor Liver Transplantation: A Pressing Need to Expand the Pool

    W. Al-hamoudi,1,2 F. Abaalkhail,2 A. Bendahmash,1 N. Allam,2 N. Almasri,2 H. Al-Bahili,2 M. Al-Sebayel,2 D. Broering,2 H. Elsiesy.2

    1Gastroenterology and Hepatology Department, King Saud University, Riyadh, Saudi Arabia; 22Department of Liver Transplantation and Hepatobiliary Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

    Background and Aims: Organ shortage has been the ongoing obstacle to expand liver transplantation world-wide. Living donor liver transplantation (LDLT) was hoped to improve this…
  • 2015 American Transplant Congress

    Preserved Kidney Volume in Living Kidney Donors: Correlation With 2 Year Renal Function Using CKD-EPI Equation to Predict Remaining GFR

    A. Khalil,1 M. Yaqub,1 T. Taber,1 J. Powelson,1 C. Sundaram,1 W. Goggins,1 D. Mishler,1 M. Mujtaba,1 A. Diez,2 A. Sharfuddin.1

    1Indiana University; 2Ohio State University, Columbus.

    Background: The aim of our study was to evaluate whether preserved kidney volume correlates with donor renal function at 2-years post-donation using the CKD-EPI eGFR…
  • 2015 American Transplant Congress

    Quantifying Altruism in Kidney Donors: How Good Are the Current Scales?

    M. McLaughlin, D. Berglund, A. Matas, H. Ibrahim.

    U of MN, Mpls.

    The decision to become a living kidney donor is complicated and altruism is certainly what drives the majority of organ donors. Unfortunately, there are no…
  • 2015 American Transplant Congress

    Lung Transplantation from Donors With Kidney Disease

    A. Ganapathi, B. Gulack, A. Castleberry, R. Davis, L. Snyder, M. Hartwig.

    Duke University Medical Center, Durham, NC.

    Background:Various donor characteristics are associated with decreased survival following single (SLT) or bilateral (BLT) lung transplantation. No current studies exist regarding use of lungs from…
  • 2015 American Transplant Congress

    Excellent Outcomes With Kidney Transplantation for Patients ≥70 Years of Age

    D. Haakinson,1 K. Reddy,1 A. Moss,1 N. Katariya,1 A. Singer,1 A. Mathur,1 J. Huskey,2 H. Khamash,2 R. Heilman.2

    1Transplant Surgery, Mayo Clinic Arizona, Phoenix, AZ; 2Nephrology, Mayo Clinic Arizona, Phoenix, AZ.

    BackgroundOur aim was to determine the outcomes following kidney transplantation in recipients ≥70 years of age at the time of transplantation.Materials and MethodsWe analyzed data…
  • 2015 American Transplant Congress

    Pro-Inflammatory Actions of New Non-HLA Antibodies Targeting Protease-Activated Receptor (PAR-1)

    R. Catar,1 C. Luecht,1 M. Simon,1 A. Philippe,1 A. Kusch,1 M. Szczepek,2 P. Hildebrand,2 P. Scheerer,2 D. Dragun.1

    1Nephrology and Intensive Care Medicine, Charité, Berlin, Germany; 2Institute of Medical Physics and Biophysics, Charité, Berlin, Germany.

    Microvascular endothelium is major target for antibodies directed against HLA and non-HLA antigens. Functional antibodies targeting G-protein coupled receptors (GPCRs) such as AT1R or ETAR…
  • 2015 American Transplant Congress

    Pharmacogenetic Variation in Renal Calcineurin Inhibitor (CNI) Metabolism and the Response of Allograft-Derived Proximal Tubule Cells

    N. Knops,1,2 L. van den Heuvel,2 R. Masereeuw,3 H. de Loor,4 E. Levtchenko,1,2 D. Kuypers.5,4

    1Pediatric Nephrology and Solid Organ Transplantation, University Hospitals Leuven, Leuven, Belgium; 2Laboratory for Pediatrics, Dept. Development & Regeneration, KU Leuven, Leuven, Belgium; 3Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, Netherlands; 4Laboratory of Nephrology, University Hospitals Leuven, Leuven, Belgium; 5Nephrology and Solid Organ Transplantation, University Hospital Leuven, Leuven, Belgium.

    Background: Multiple studies have demonstrated the importance of genetic variation in CYP3A5 and ABCB1 for calcineurin inhibitor (CNI) disposition and CNI-related nephrotoxicity. Renal CNI metabolism…
  • 2015 American Transplant Congress

    Accurate Prediction of High-Resolution HLA-A, -B, -C, -DRB1 and -DQB1 Typing and Low-Resolution HLA-DQA1 Typing by Haplotype Analysis

    A. Jaramillo,1 R. Vaidya,2 M. Pando,3 S. Gaitonde.4

    1Histocompatibility & Immunogenetics Laboratory, Gift of Hope Organ & Tissue Donor Network, Itasca, IL; 2College of Pharmacy, Roseman University of Health Sciences, South Jordan, UT; 3Department of Laboratory Medicine & Pathology, Mayo Clinic, Phoenix, AZ; 4Department of Pathology, University of Illinois, Chicago, IL.

    Aim: Allele-specific HLA antibodies are commonly detected by Luminex single antigen bead assays in solid organ transplant recipients. However, high-resolution HLA typing for deceased donors…
  • 2015 American Transplant Congress

    Inhibition of mTOR Modulates SLPI Expression: A Potential Role in Kidney Transplant Patients

    N. Ambrosi,1 A. Dotta,2 C. Pizarro,2 D. Guerrieri,1 A. Gonzalez,2 C. Leiva,2 L. Leon,2 J. Mendiberri,3 M. Rial,2 C. Incardona,4 E. Chuluyan,1 D. Casadei.2

    1CEFYBO, UBA, Buenos Aires, Argentina; 2Fundacion 3er Milenio, INBA, Buenos Aires, Argentina; 3UNICEN, Olavarria, Argentina; 4Fundación GADOR, Buenos Aires, Argentina.

    Secretory leukocyte protease inhibitor (SLPI) is a serine protease inhibitor secreted by inflammatory and epithelial cells. It functions as an endogenous immunomodulatory, with antiinflammatory and…
  • 2015 American Transplant Congress

    Clinical and Biochemical Results of BK Virus Nephropathy in Kidney Allograft Recipients

    B. Canbakan,1 I. Akdağ,1 ö. Merhametsiz,1 ö. Yayar,2 E. Oğuz,1 M. Kiliç,3 D. Ayli.1

    1Nephrology, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey; 2Nephrology, Atatürk Training and Research Hospital, Ankara, Turkey; 3General Surgery, Atatürk Training and Research Hospital, Ankara, Turkey.

    BK virus (BKV) nephropathy has emerged as a significant cause of graft dysfuction in kidney allograft recipients after using powerful immunosupressive treatment protocols in recent…
  • « Previous Page
  • 1
  • …
  • 147
  • 148
  • 149
  • 150
  • 151
  • …
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences